Publication | Closed Access

Patient treatment preference in advanced breast cancer: A randomized cross-over study of doxorubicin and mitozantrone

Advanced Breast CancerBreast OncologyOncologyRandomized Cross-over StudyCancer ManagementClinical TrialsBreast CancerPharmacotherapyCancer TreatmentMedicineRadiation OncologyPatient Treatment PreferenceHealth Sciences